市場調查報告書
商品編碼
1494788
2030 年精細化學品市場預測:按產品、材料、功能、應用、最終用戶和地區分類的全球分析Fine Chemicals Market Forecasts to 2030 - Global Analysis By Product, Material, Functionality, Application, End User and By Geography |
根據Stratistics MRC的數據,2024年全球精細化學品市場規模為1,514.1億美元,預計將以9.2%的複合年成長率成長,到2030年將達到2,567.5億美元。
精細化學品是針對特定應用而生產的相對少量的高純度化學品。這些化學品經過精確的合成和精製過程,以滿足嚴格的品質標準。這些化學物質的特點是成分精確、純度高(通常超過 99%)。它們的特徵是分子結構複雜,用於精確的化學和物理特性,而不是大量使用。
美國國家衛生統計中心公佈的美國治療藥物使用資料顯示,2020年,透過醫生就診訂購和提供的藥品以及透過醫院急診就診給藥的藥品約29億種。
日益關注特種化學品
特種化學品具有獨特的性能和用途,需要精確的配方和高度純化的原料,通常屬於精細化學品的範疇。隨著製藥、電子和農業化學品等行業對特定應用的專用化學品的需求不斷增加,對精細化學品的需求也不斷增加。這一趨勢正在推動精細化工產業的創新、投資和擴張,推動整體市場成長並提升其在各個工業領域的重要性。
複雜的合成過程
精細化學品需要複雜的合成工藝,這主要是由於製藥和特種化學品等行業對純度和品質的嚴格要求。此類過程通常涉及複雜的化學反應、反應條件的精確控制以及多個精製步驟以實現所需的純度和功能。然而,這些工藝的複雜性增加了製造成本和上市時間,阻礙了市場成長。
契約製造的成長
合約開發和受託製造廠商(CDMO) 代表製藥、生物技術和特種化學品公司提供專業知識和設備來製造精細化學品。這種外包趨勢使客戶能夠專注於自己的核心能力,同時利用 CDMO 功能進行高效且具成本效益的生產。對外包服務的需求不斷增加,特別是在藥物開發領域,直接增加了對精細化學品的需求,推動了市場的成長和擴張。
專利到期和非專利競爭
當品牌藥的專利到期時,學名藥以較低的價格進入市場,從而減少了對其製造中使用的精細化學品的需求。這加劇了精細化學品製造商之間的競爭,往往導致價格下降和利潤率縮小。此外,學名藥使用更簡單的化學配方,這可能會降低所需精細化學品的複雜性和數量。因此,專利到期和非專利競爭可能會阻礙精細化學品市場的成長前景。
COVID-19 的影響
由於供應鏈中斷、勞動力短缺以及製藥和汽車等關鍵行業的需求減少,COVID-19 大流行最初擾亂了精細化學品市場。然而,隨著製藥業大力開發疫苗和治療方法,市場也逐漸復甦。此外,衛生和健康標準意識的提高也增加了對消毒劑和個人保健產品中使用的精細化學品的需求。整體而言,疫情加速了精細化學品市場的某些領域的發展,同時也為其他領域帶來了暫時的挑戰。
生物基原料產業預計將在預測期內成為最大的產業
生物基原料領域預計將出現良好成長。生物基原料提供了傳統石化原料的永續,並且在精細化學品的生產中變得越來越重要。這些原料源自於生質能、農業殘留物和廢棄物等可再生資源,為化學製造提供了環保的方法。透過利用生物基原料,精細化工產業可以減少其環境足跡,減少對石化燃料的依賴,並為更永續和循環的經濟做出貢獻,同時保持高品質的產品標準。
預計藥物發現和開發領域在預測期內的複合年成長率最高。
預計藥物發現和藥物開發領域在預測期內將出現最高的複合年成長率。精細化學品透過提供藥物研究必需的高品質、純物質,在藥物發現和開發中發揮重要作用。這些化學物質有多種用途,包括活性藥物成分 (API) 合成、配方開發和分析測試。這些化學物質使研究人員能夠創造新的化合物、最佳化配方並確保產品的安全性和功效。
由於製藥、農業化學品和特種化學品行業的成長,預計亞太地區在預測期內將佔據最大的市場佔有率。推動市場成長的因素包括醫療保健支出的增加、人口的成長和工業化的擴大。此外,稅收優惠和法律規範等有利的政府舉措正在吸引對精細化學品行業的投資。整體而言,在不同最終用戶產業的需求和新興市場持續開拓的推動下,亞太地區精細化學品市場有望顯著成長。
在製藥、農業化學品和特種化學品行業強勁需求的推動下,預計北美在預測期內將呈現最高的複合年成長率。該地區注重研究和創新,擁有先進的製造能力和嚴格的監管標準,確保了高品質的產品。不斷增加的研發投資,加上永續性意識的不斷增強,正在塑造市場格局。整體而言,北美精細化學品市場持續蓬勃發展,為各產業提供廣泛的特種產品和解決方案。
According to Stratistics MRC, the Global Fine Chemicals Market is accounted for $151.41 billion in 2024 and is expected to reach $256.75 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Fine chemicals are high-purity chemical substances produced in relatively small quantities for specific applications. These chemicals undergo precise synthesis and purification processes to meet stringent quality standards. They are distinguished by their exact composition and high level of purity, often exceeding 99%. They are characterized by their complex molecular structures and are utilized for their precise chemical and physical properties rather than their bulk quantities.
According to the data on therapeutic drug use in the U.S. published by National Centre for Health Statistics, the number of drugs that were ordered and provided through physician office visits reached around 2.9 billion, and the number of drugs that were given or prescribed through hospital emergency department visits reached around 336 million in 2020.
Rising focus on specialty chemicals
Specialty chemicals, characterized by unique properties and applications, require precise formulations and high-purity ingredients, often falling within the realm of fine chemicals. As industries such as pharmaceuticals, electronics, and agrochemicals increasingly demand specialty chemicals for specific purposes, the need for fine chemicals also grows. This trend fuels innovation, investment, and expansion in the fine chemicals sector, driving its overall market growth and contributing to its significance in various industrial segments.
Complex synthesis processes
Fine chemicals have complex synthesis processes primarily due to the stringent purity and quality requirements demanded by industries like pharmaceuticals and specialty chemicals. These processes often involve intricate chemical reactions, precise control of reaction conditions, and multiple purification steps to achieve the desired level of purity and functionality. However, the complexity of these processes increases production costs and time-to-market, hampering market growth.
Growth in contract manufacturing
Contract development and manufacturing organizations (CDMOs) offer specialized expertise and facilities for the production of fine chemicals on behalf of pharmaceutical, biotechnology, and specialty chemical companies. This outsourcing trend allows clients to focus on core competencies while leveraging the CDMOs' capabilities for efficient and cost-effective production. As the demand for outsourcing services increases, particularly in pharmaceutical drug development, it directly propels the demand for fine chemicals, driving market growth and expansion.
Patent expirations and generic competition
When patents for branded drugs expire, generic versions enter the market at lower prices, leading to reduced demand for fine chemicals used in their production. This intensifies competition among fine chemical manufacturers, often resulting in price erosion and shrinking profit margins. Additionally, generic drugs may utilize simpler chemical formulations, reducing the complexity and volume of fine chemicals required. As a result, patent expirations and generic competition can hinder the growth prospects of the fine chemicals market.
Covid-19 Impact
The covid-19 pandemic initially disrupted the fine chemicals market due to supply chain disruptions, labor shortages, and reduced demand from key industries like pharmaceuticals and automotive. However, the market gradually rebounded as the pharmaceutical sector surged to develop vaccines and treatments. Additionally, increased awareness of hygiene and health standards boosted demand for fine chemicals used in disinfectants and personal care products. Overall, the pandemic accelerated certain segments while posing temporary challenges to others within the fine chemicals market.
The bio-based feedstocks segment is expected to be the largest during the forecast period
The bio-based feedstocks segment is estimated to have a lucrative growth. Bio-based feedstocks are becoming increasingly important in the production of fine chemicals, offering sustainable alternatives to traditional petrochemical sources. These materials, derived from renewable sources such as biomass, agricultural residues, or waste streams, provide a greener approach to chemical manufacturing. By harnessing bio-based feedstocks, fine chemical industries can reduce their environmental footprint, decrease dependence on fossil fuels, and contribute to a more sustainable and circular economy while maintaining high-quality product standards.
The drug discovery & development segment is expected to have the highest CAGR during the forecast period
The drug discovery & development segment is anticipated to witness the highest CAGR growth during the forecast period. Fine chemicals play a crucial role in drug discovery and development by providing high-quality, pure substances essential for pharmaceutical research. These chemicals serve various purposes, including synthesis of active pharmaceutical ingredients (APIs), formulation development, and analytical testing. They enable researchers to create novel compounds, optimize drug formulations, and ensure product safety and efficacy.
Asia Pacific is projected to hold the largest market share during the forecast period due to its growing pharmaceutical, agrochemical, and specialty chemicals industries. Factors driving market growth include increasing healthcare expenditure, rising population, and expanding industrialization. Moreover, favourable government initiatives, such as tax incentives and supportive regulatory frameworks, attract investments in the fine chemicals sector. Overall, the Asia Pacific fine chemicals market is poised for substantial growth, fuelled by demand from diverse end-user industries and ongoing industrial developments.
North America is projected to have the highest CAGR over the forecast period, driven by robust demand from pharmaceutical, agrochemical, and specialty chemical sectors. With a strong emphasis on research and innovation, the region boasts advanced manufacturing capabilities and stringent regulatory standards, ensuring high-quality products. Increasing investments in R&D, coupled with growing awareness of sustainability, are shaping the market landscape. Overall, the North American fine chemicals market continues to thrive, offering a wide range of specialty products and solutions to various industries.
Key players in the market
Some of the key players profiled in the Fine Chemicals Market include BASF SE, Merck KGaA, Lonza Group, Evonik Industries AG, DSM Corporation, Johnson Matthey, Albemarle Corporation, Clariant AG, Arkema SA, Sumitomo Chemical Corporation, Pfizer Inc., Huntsman Corporation, Univar Solutions Inc., Mitsui Chemicals Inc., W. R. Grace & Co., Novasep, Denisco Corporation, TCI Chemicals, Kenko Corporation and Solvay SA.
In May 2024, BASF launched a new insecticide 'Efficon' to counter the threat posed by piercing and sucking pests causing extensive damage amounting to 35 to 40% loss in the productivity and yield of the produce to agricultural crops in India.
In June 2023, Univar Solutions Inc., a prominent global supplier of specialized chemicals and ingredients, announced a partnership with W.R. Grace & Co. This strategic collaboration involves the distribution of W.R. Grace & Co.'s renowned product, SYLOID FP silica. This specific product plays a pivotal role as a versatile ingredient in the formulation of prescription drugs, over-the-counter pharmaceutical solutions, and dietary supplements.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.